OTC · Biotechnology

Ampio Pharmaceuticals, Inc. (AMPE) Stock

$0.18 +0.00% OTC: AMPE Healthcare

Ampio Pharmaceuticals, Inc., headquartered in Englewood, Colorado, is a biopharmaceutical firm dedicated to advancing immunomodulatory therapeutics primarily for the management of osteoarthritis pain across the United States. Their developmental pipeline currently features several compounds: AP-013, an intra-articular injection, is undergoing Phase III clinical trials for knee osteoarthritis.

Valuation

MetricValue
Price$0.18
Market Cap$207884
P/E Ratio-0.02
P/B Ratio0.04
P/S Ratio0.00
EPS (TTM)$-10.66
52-Week High$0.64
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-113.96%
ROA-150.49%
ROCE-283.27%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.08
Current Ratio2.41

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-19.0M$-16.0M$-21.0M$-20.0M$-10.0M
Net Profit$-14.0M$-16.0M$-17.0M$-16.0M$-9.0M
EPS$-18.32$-27.59$-18.59$-29.32$-10.66
Op Margin—————

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$14.0M$23.0M$39.0M$14.0M$6.0M
Total Liabilities$8.0M$5.0M$12.0M$2.0M$2.0M
Cash$7.0M$17.0M$34.0M$13.0M$4.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-15.0M$-15.0M$-14.0M$-21.0M$-9.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$-12.0M$-1.0M$-2.0M$0$0
Net Cash Flow$-1.0M$11.0M$17.0M$-21.0M$-9.0M
Free Cash Flow$-15.0M$-15.0M$-14.0M$-21.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.43
FCF Yield-4119.61%
Quick Ratio2.41
Interest Coverage0.00
Return 1Y6681.48%
Return 3Y-96.16%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.04%
Institutions Float Held0.04%
Institutional HolderSharesReport Date
Cypress Capital Management, LLC (WY)4402026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALZN $1.35 +0.75% -0.11 $5.14M 0.00%
ATNM $0.80 +1.32% -1.07 $25.02M 0.00%
AVTX $18.97 +2.87% -2.79 $214.25M 0.00%
BNTC $13.07 -0.46% -11.78 $449.01M 0.00%
OGEN $0.50 -1.96% -0.14 $2.26M 0.00%

About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc., headquartered in Englewood, Colorado, is a biopharmaceutical firm dedicated to advancing immunomodulatory therapeutics primarily for the management of osteoarthritis pain across the United States. Their developmental pipeline currently features several compounds: AP-013, an intra-articular injection, is undergoing Phase III clinical trials for knee osteoarthritis. Additionally, the company has multiple candidates addressing COVID-19: AP-017, an intravenous Ampion formulation, is in Phase II for adult COVID-19 patients who require supplemental oxygen; AP-019, an inhaled Ampion treatment, also in Phase II, targets adults experiencing respiratory distress from COVID-19; while AP-018, currently in Phase I, aims to treat individuals with persistent respiratory symptoms following COVID-19 infection.

Ampio Pharmaceuticals, Inc. is headquartered in US.

Ampio Pharmaceuticals, Inc. (AMPE) stock trades at $0.18 with a market capitalization of $207884. The stock is valued at a price-to-earnings (P/E) ratio of -0.02, price-to-book of 0.04, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.64, and currently trades 71.9% below its 52-week high.

On profitability, Ampio Pharmaceuticals, Inc. generates a return on equity (ROE) of -113.96%, return on capital employed of -283.27%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.ampiopharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides